Ken Rubinstein

Swift Sync, Inc. is a medical device company that provides a temporary a-v sequential pacing system to address cardiac perforation, dislodgement, and limitations associated with traditional pacing catheters. The company is based in Miami, FL. The company's patented design self-positions on the right side chambers of the heart, stays securely in place, and maintains endocardium contact for synchronous dual-chamber pacing. Swift Sync's pacing catheter can be placed without fluoroscopic guidance and is indicated for use in operating rooms, cath labs, ER, ICU, and CCU. The company was founded in 2021. The CEO is Richard B. Toren.

Swift Sync, Inc. is a medical device company that provides a temporary a-v sequential pacing system to address cardiac perforation, dislodgement, and limitations associated with traditional pacing catheters. The company is based in Miami, FL. The company's patented design self-positions on the right side chambers of the heart, stays securely in place, and maintains endocardium contact for synchronous dual-chamber pacing. Swift Sync's pacing catheter can be placed without fluoroscopic guidance and is indicated for use in operating rooms, cath labs, ER, ICU, and CCU. The company was founded in 2021. The CEO is Richard B. Toren.

Swift Sync, Inc. is a medical device company that provides a temporary a-v sequential pacing system to address cardiac perforation, dislodgement, and limitations associated with traditional pacing catheters. The company is based in Miami, FL. The company's patented design self-positions on the right side chambers of the heart, stays securely in place, and maintains endocardium contact for synchronous dual-chamber pacing. Swift Sync's pacing catheter can be placed without fluoroscopic guidance and is indicated for use in operating rooms, cath labs, ER, ICU, and CCU. The company was founded in 2021. The CEO is Richard B. Toren.

Swift Sync, Inc. is a medical device company that provides a temporary a-v sequential pacing system to address cardiac perforation, dislodgement, and limitations associated with traditional pacing catheters. The company is based in Miami, FL. The company's patented design self-positions on the right side chambers of the heart, stays securely in place, and maintains endocardium contact for synchronous dual-chamber pacing. Swift Sync's pacing catheter can be placed without fluoroscopic guidance and is indicated for use in operating rooms, cath labs, ER, ICU, and CCU. The company was founded in 2021. The CEO is Richard B. Toren.

Swift Sync, Inc. is a medical device company that provides a temporary a-v sequential pacing system to address cardiac perforation, dislodgement, and limitations associated with traditional pacing catheters. The company is based in Miami, FL. The company's patented design self-positions on the right side chambers of the heart, stays securely in place, and maintains endocardium contact for synchronous dual-chamber pacing. Swift Sync's pacing catheter can be placed without fluoroscopic guidance and is indicated for use in operating rooms, cath labs, ER, ICU, and CCU. The company was founded in 2021. The CEO is Richard B. Toren.